Clinical trial NCT01532219: Internet-delivered Psychodynamic Therapy for Depression and Anxiety Disorders
Official title: Internet-delivered Psychodynamic Therapy for Depression and Anxiety Disorders: A Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Depression
Anxiety
Lead sponsor: Linkoeping University
Sponsor class: OTHER_GOV
First posted: 2012-02-14
Enrollment: 100
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The overall aim of this study is to develop and test a psychodynamic Internet-delivered psychological treatment for patients with major depression and/or anxiety disorders and compare its efficacy to an active control group.


Eligibility criteria: Inclusion Criteria:

* Clinical diagnosis of Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, Generalized Anxiety disorder, Depressive Disorder NOS or Anxiety Disorder NOS
* 10 or higher on the PHQ-9 or on the GAD-7 at pre-treatment

Exclusion Criteria:

* Primary diagnosis of Obsessive Compulsive Disorder or Post-traumatic Stress Disorder
* Severe psychiatric condition (e.g. psychosis or bipolar disorder)
* Alcohol abuse (more than 16 on the AUDIT)
* Suicidal (measured in diagnostic interview)
* Changed medication during the last three months

Primary outcomes:
measure: 9-item Patient Health Questionnaire Depression Scale (PHQ-9)
timeFrame: Two weeks before the treatment starts
measure: 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)
timeFrame: Two weeks before the treatment starts
measure: 9-item Patient Health Questionnaire Depression Scale (PHQ-9)
timeFrame: At treatment start (0 weeks)
measure: 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)
timeFrame: At treatment start (0 weeks)
measure: 9-item Patient Health Questionnaire Depression Scale (PHQ-9)
timeFrame: At treatment termination (10 weeks)
measure: 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)
timeFrame: At treatment termination (10 weeks)
measure: 9-item Patient Health Questionnaire Depression Scale (PHQ-9)
timeFrame: At treatment follow-up (7 months)
measure: 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)
timeFrame: At treatment follow-up (7 months)
Secondary outcomes:
measure: Emotional Processing Scale (EPS-25)
timeFrame: Two weeks before the treatment starts
measure: Emotional Processing Scale (EPS-25)
timeFrame: At treatment start (0 weeks)
measure: Emotional Processing Scale (EPS-25)
timeFrame: At treatment termination (10 weeks)
measure: Five Facets of Mindfulness Questionnaire (FFMQ)
timeFrame: Two weeks before the treatment starts
measure: Five Facets of Mindfulness Questionnaire (FFMQ)
timeFrame: At treatment start (0 weeks)
measure: Five Facets of Mindfulness Questionnaire (FFMQ)
timeFrame: At treatment termination (10 weeks)
measure: Emotional Processing Scale (EPS-25)
timeFrame: At treatment follow-up (7 months)
measure: Five Facets of Mindfulness Questionnaire (FFMQ)
timeFrame: At treatment follow-up (7 months)
Other outcomes:
Locations:
city: Linköping
country: Sweden
facility: Linköping University, Department of Behavioral Sciences and Learning
Study officials:
References: